메뉴 건너뛰기




Volumn 62, Issue 3, 2013, Pages 181-190

Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: A randomized, controlled, noninferiority trial

(22)  Natsuaki, Masahiro a   Kozuma, Ken b   Morimoto, Takeshi c   Kadota, Kazushige d   Muramatsu, Toshiya e   Nakagawa, Yoshihisa f   Akasaka, Takashi g   Igarashi, Keiichi h   Tanabe, Kengo i   Morino, Yoshihiro j   Ishikawa, Tetsuya k   Nishikawa, Hideo l   Awata, Masaki m   Abe, Mitsuru n   Okada, Hisayuki o   Takatsu, Yoshiki p   Ogata, Nobuhiko q   Kimura, Kazuo r   Urasawa, Kazushi s   Tarutani, Yasuhiro t   more..


Author keywords

biolimus eluting stent(s); everolimus eluting stent(s); percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; EVEROLIMUS; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; UMIROLIMUS;

EID: 84880062427     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.04.045     Document Type: Article
Times cited : (193)

References (8)
  • 1
    • 84859586982 scopus 로고    scopus 로고
    • Stent thrombosis with drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis
    • T. Palmerini, G. Biondi-Zoccai, and D. Della Riva Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402
    • (2012) Lancet , vol.379 , pp. 1393-1402
    • Palmerini, T.1    Biondi-Zoccai, G.2    Della Riva, D.3
  • 2
    • 84874443706 scopus 로고    scopus 로고
    • Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): A randomised, controlled, non-inferiority trial
    • P.C. Smits, S. Hofma, and M. Togni Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial Lancet 381 2013 651 660
    • (2013) Lancet , vol.381 , pp. 651-660
    • Smits, P.C.1    Hofma, S.2    Togni, M.3
  • 3
    • 84860481375 scopus 로고    scopus 로고
    • Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan
    • T. Kimura, T. Morimoto, and Y. Furukawa Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan Cardiovasc Interv Ther 26 2011 234 245
    • (2011) Cardiovasc Interv Ther , vol.26 , pp. 234-245
    • Kimura, T.1    Morimoto, T.2    Furukawa, Y.3
  • 4
    • 84874441236 scopus 로고    scopus 로고
    • Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): A randomised non-inferiority trial
    • E.H. Christiansen, L.O. Jensen, and P. Thayssen Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial Lancet 381 2013 661 669
    • (2013) Lancet , vol.381 , pp. 661-669
    • Christiansen, E.H.1    Jensen, L.O.2    Thayssen, P.3
  • 5
    • 79954633893 scopus 로고    scopus 로고
    • Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings
    • K. Kolandaivelu, R. Swaminathan, and W.J. Gibson Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings Circulation 123 2011 1400 1409
    • (2011) Circulation , vol.123 , pp. 1400-1409
    • Kolandaivelu, K.1    Swaminathan, R.2    Gibson, W.J.3
  • 6
    • 84857053550 scopus 로고    scopus 로고
    • Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: Five-year outcome of the j-Cypher registry
    • for the j-Cypher Registry Investigators
    • T. Kimura, T. Morimoto, Y. Nakagawa for the j-Cypher Registry Investigators Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher registry Circulation 125 2012 584 591
    • (2012) Circulation , vol.125 , pp. 584-591
    • Kimura, T.1    Morimoto, T.2    Nakagawa, Y.3
  • 7
    • 82755195016 scopus 로고    scopus 로고
    • Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial
    • G.G. Stefanini, B. Kalesan, and P.W. Serruys Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial Lancet 378 2011 1940 1948
    • (2011) Lancet , vol.378 , pp. 1940-1948
    • Stefanini, G.G.1    Kalesan, B.2    Serruys, P.W.3
  • 8
    • 80052506035 scopus 로고    scopus 로고
    • Evaluating the 'all-comers' design: A comparison of participants in two 'all-comers' PCI trials with non-participants
    • S.P. De Boer, M.J. Lenzen, and R.M. Oemrawsingh Evaluating the 'all-comers' design: a comparison of participants in two 'all-comers' PCI trials with non-participants Eur Heart J 32 2011 2161 2167
    • (2011) Eur Heart J , vol.32 , pp. 2161-2167
    • De Boer, S.P.1    Lenzen, M.J.2    Oemrawsingh, R.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.